1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. INDUSTRIAL BIOTECHNOLOGY MARKET BY TECHNOLOGY
5.1. Introduction
5.2. Fermentation
5.3. Genetic Engineering
5.4. Others
6. INDUSTRIAL BIOTECHNOLOGY MARKET BY RAW MATERIALS
6.1. Introduction
6.2. Enzymes
6.3. Microorganisms
6.3.1. Bacteria
6.3.2. Yeast
6.3.3. Others
7. INDUSTRIAL BIOTECHNOLOGY MARKET BY APPLICATION
7.1. Introduction
7.2. Biofuel
7.3. Biopolymer
7.4. Biochemicals
7.5. Biomedicines
7.6. Others
8. INDUSTRIAL BIOTECHNOLOGY MARKET BY END-USER
8.1. Introduction
8.2. Pharmaceutical
8.3. Food & Beverage
8.4. Chemical
8.5. Energy & Power
8.6. Textiles
8.7. Others
9. INDUSTRIAL BIOTECHNOLOGY MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. United Kingdom
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Others
9.5. Middle East & Africa
9.5.1. Saudi Arabia
9.5.2. United Aran Emirates
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Taiwan
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Novonesis Group
11.2. Dsm-Firmenich
11.3. Brain Biotech AG
11.4. Zytex Corporation
11.5. Amgen Inc.
11.6. Sana Biotechnology.
11.7. Capra Biosciences
11.8. BioVeritas, LLC
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations